Kathleen McElhone

3.2k total citations
39 papers, 1.9k citations indexed

About

Kathleen McElhone is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Kathleen McElhone has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 14 papers in Dermatology and 14 papers in Rheumatology. Recurrent topics in Kathleen McElhone's work include Psoriasis: Treatment and Pathogenesis (22 papers), Systemic Lupus Erythematosus Research (14 papers) and Dermatology and Skin Diseases (13 papers). Kathleen McElhone is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (22 papers), Systemic Lupus Erythematosus Research (14 papers) and Dermatology and Skin Diseases (13 papers). Kathleen McElhone collaborates with scholars based in United Kingdom, United States and Australia. Kathleen McElhone's co-authors include Janice Abbott, C.E.M. Griffiths, Lee‐Suan Teh, A. David Burden, Richard B. Warren, Catherine Smith, Nick J. Reynolds, Mark Lunt, Darren M. Ashcroft and Zenas Z N Yiu and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Investigative Dermatology and British Journal of Dermatology.

In The Last Decade

Kathleen McElhone

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen McElhone United Kingdom	21	1.3k	902	572	339	237	39	1.9k
Shiraz R. Gupta United States	15	700 0.5×	151 0.2×	366 0.6×	123 0.4×	237 1.0×	20	1.2k
I. Gilloteau United States	18	504 0.4×	169 0.2×	302 0.5×	101 0.3×	172 0.7×	48	998
Robert Boggs United States	16	734 0.6×	541 0.6×	267 0.5×	41 0.1×	80 0.3×	34	1.2k
K Malottki United Kingdom	11	238 0.2×	166 0.2×	99 0.2×	63 0.2×	124 0.5×	17	725
Jörg Ruof Germany	21	197 0.2×	635 0.7×	27 0.0×	97 0.3×	401 1.7×	67	1.4k
Brian Calimlim United States	19	136 0.1×	228 0.3×	813 1.4×	55 0.2×	39 0.2×	70	1.4k
Liza Takiya United States	15	85 0.1×	267 0.3×	137 0.2×	52 0.2×	86 0.4×	47	888
Meghna Jani United Kingdom	17	314 0.2×	486 0.5×	29 0.1×	60 0.2×	19 0.1×	60	1.1k
Christine Iannaccone United States	23	181 0.1×	1.1k 1.2×	18 0.0×	244 0.7×	34 0.1×	62	1.8k
Jonathan Graf United States	21	168 0.1×	626 0.7×	41 0.1×	144 0.4×	20 0.1×	42	1.3k

Countries citing papers authored by Kathleen McElhone

Since Specialization

Citations

This map shows the geographic impact of Kathleen McElhone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen McElhone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen McElhone more than expected).

Fields of papers citing papers by Kathleen McElhone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen McElhone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen McElhone. The network helps show where Kathleen McElhone may publish in the future.

Co-authorship network of co-authors of Kathleen McElhone

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen McElhone. A scholar is included among the top collaborators of Kathleen McElhone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen McElhone. Kathleen McElhone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology. 35(8). e496–e498. 3 indexed citations

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology. 35(8). e498–e501. 4 indexed citations

McElhone, Kathleen, Janice Abbott, M. A. Hurley, et al.. (2020). . CLOK (University of Central Lancashire). 6 indexed citations

Yiu, Zenas Z N, K.J. Mason, Juliet N. Barker, et al.. (2019). A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. British Journal of Dermatology. 181(6). 1265–1271. 16 indexed citations

Mason, K.J., Zenas Z N Yiu, Kathleen McElhone, et al.. (2019). Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review. British Journal of Dermatology. 181(2). 256–264. 16 indexed citations

Mason, K.J., Mark Lunt, Kathleen McElhone, et al.. (2018). 509 Association between biologics and major cardiovascular events in adult patients with plaque psoriasis: A cohort study in the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology. 138(5). S87–S87. 1 indexed citations

Yiu, Zenas Z N, Darren M. Ashcroft, Ian Evans, et al.. (2018). Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register ( BADBIR ). British Journal of Dermatology. 180(2). 329–337. 26 indexed citations

Mason, K.J., Mark Lunt, H.J.A. Hunter, et al.. (2017). Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology. 177(5). 1 indexed citations

Warren, Richard B., K.J. Mason, Kathleen McElhone, et al.. (2017). Identification of factors that may influence the selection of first‐line biological therapy for people with psoriasis: a prospective, multicentre cohort study. British Journal of Dermatology. 177(3). 828–836. 14 indexed citations

10.

Thompson, Alexander, Alex Turner, Louise Longworth, et al.. (2017). Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. Value in Health. 21(8). 1010–1018. 18 indexed citations

11.

Iskandar, Ireny, Richard B. Warren, Mark Lunt, et al.. (2016). 018 Impact of biologic therapies on the quality of life of psoriasis patients: results from the British Association of Dermatologists’ Biologic Interventions Register. Journal of Investigative Dermatology. 136(9). S163–S163. 1 indexed citations

12.

Warren, Richard B., Catherine Smith, Zenas Z N Yiu, et al.. (2015). Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology. 135(11). 2632–2640. 276 indexed citations

13.

McElhone, Kathleen, Chris Sutton, Janice Abbott, et al.. (2014). Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?. Value in Health. 17(7). A538–A538. 1 indexed citations

14.

Meacock, Rachel, Mark Harrison, Kathleen McElhone, et al.. (2014). Mapping the disease-specific LupusQoL to the SF-6D. Quality of Life Research. 24(7). 1749–1758. 9 indexed citations

15.

Castelino, Madhura, Janice Abbott, Kathleen McElhone, & Lee‐Suan Teh. (2012). Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature. Lara D. Veeken. 52(4). 684–696. 25 indexed citations

16.

Jolly, Meenakshi, A. Simon Pickard, Carlo Wilke, et al.. (2009). Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Annals of the Rheumatic Diseases. 69(1). 29–33. 67 indexed citations

17.

Yee, Chee‐Seng, Kathleen McElhone, Lee‐Suan Teh, & Caroline Gordon. (2009). Assessment of disease activity and quality of life in systemic lupus erythematosus – New aspects. Best Practice & Research Clinical Rheumatology. 23(4). 457–467. 31 indexed citations

18.

McElhone, Kathleen, Lee‐Suan Teh, & Janice Abbott. (2008). Reply. Arthritis Care & Research. 59(7). 1048–1049. 1 indexed citations

19.

McElhone, Kathleen, Janice Abbott, J. Shelmerdine, et al.. (2007). Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Care & Research. 57(6). 972–979. 239 indexed citations

20.

Buckler, Helen, Kathleen McElhone, Paul N. Durrington, et al.. (1998). The effects of low‐dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women. Clinical Endocrinology. 49(2). 173–178. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact